MAPK1 and cancer: Combining our observations in the hepatic-Erk1R84H mice with the observations in Erk1R84H- and Erk1R84S-transformed cells and also with those in cancerous cell lines, it seems that, at least in some cancers, a low, barely detectable, Erk activity is associated with the transformed phenotype.